Where we at?, page-233

I agree that is has the potential to rerate very quickly on any good news. The problem I have is that shareholders are given the mushroom treatment and a significant amount of the information we have been fed on funding & partnerships has turned out to be BS.
I would love to know what non dilutive funding options are available to them, If I was confident on them getting further funding I would probably buy more as the current SP certainly has a lot of bad news baked into it. But atm I'm far from convinced.
I still can't get my mind round the fact that we are this far down the track without any definitive news about partnerships and an SP of 28.5c. I wouldn't have believed it was possible a year ago unless something went drastically wrong with the trials.
Yet here we are